Entero Therapeutics Inc. (ENTO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Entero Therapeutics Inc.

NASDAQ: ENTO · Real-Time Price · USD
3.15
0.85 (36.96%)
At close: Sep 12, 2025, 3:59 PM
3.08
-2.22%
After-hours: Sep 12, 2025, 06:12 PM EDT

Entero Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-17.08M -24.89M -18.06M -9.92M -10.78M -6.16M -15.79M -11.7M -3.87M -5.09M -10.65M -21.82M -56.61M -51.21M -41.59M -30.44M -39.68K -35.1K
Depreciation & Amortization
1.34K 36.65K 48.95K 56.27K 62.25K 34.25K 29.27K 21.96K 36.93K 60.44K 83.62K 215.97K 331.68K 300.99K 270.62K 138.41K 549.99 557.44
Stock-Based Compensation
228.31K 360.19K 631.55K 713.02K 792.7K 953.52K 1.04M 914.52K 742.83K 450.5K 92.52K 92.54K 1.08K 1.02K 2.49K 2.38K 2.37K 2.09K
Other Working Capital
1.03M 1.38M 958.94K 303.97K -69.5K 1.17K 2.26K 1K -8.25M -8.02M -7.71M 6.38M 14.92M 14.69M 14.38M 298.34K 10.45K 13.33K
Other Non-Cash Items
12.02M 11.55M 16.24M 5.65M 5.72M 4.95M 157.02K 122.29K 671.35K 942.3K 286.61K 22.6M 8.61M 8.32M 8.96M -13.35M 4.36K 4.08K
Deferred Income Tax
n/a 4.26M -10.6M -10.6M -10.6M -14.86M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
1.93M 2.39M 2.53M 1.62M 833.74K 1.8M 2.19M 1.7M -6.8M -7.5M -7M -8.39M 14.6M 14.18M 12.84M 14.24M 13.12K 13.37K
Operating Cash Flow
-2.89M -6.29M -9.22M -12.49M -13.97M -13.28M -12.38M -8.94M -9.87M -11.69M -16.76M -22.61M -34.09M -29.51M -21.6M -15.75M -19.28K -15K
Capital Expenditures
n/a n/a -4 -500K -500K -500K -500K n/a n/a n/a n/a 1.96K -10.25M -10.25M -10.25M -10.25M -75.29 0.17
Cash Acquisitions
n/a n/a 88.17K 88.17K 88.17K 88.17K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -500 -500 -500 -500 n/a n/a n/a n/a -10.25K 8.99M 8.99M 8.99M 9M 91.52 91.52
Investing Cash Flow
n/a n/a 88.17K 87.67K 87.67K 87.67K -500 n/a n/a n/a n/a 1.96K -1.25M -1.25M -1.25M -1.25M 16.23 91.69
Debt Repayment
490.64K 281.43K -644.58K -612.78K -588.7K -606.4K -603.49K -603.49K -611.92K -625.87K -641.24K n/a 22.34K 55.68K 88.83K -10 1.95K 42.46K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-163.43K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
163.43K 36.00 45.00 -4.22M -2.24M 365.00 657.00 4.09M -2.26M -4.5M -6.92M -5.05M 5.91M 15.73M 13.23M 13.23M 4.91M -4.91M
Financial Cash Flow
2.22M 2.9M 5.58M 9.97M 13.81M 15.06M 15.23M 10.87M 10.26M 8.4M 10.22M 17.04M 28.37M 28.3M 22.94M 16.12M 26.44K 25.34K
Net Cash Flow
-672.52K -3.39M -3.55M -2.93M -573.58K 1.37M 2.35M 1.93M 374.86K -3.34M -6.59M -5.55M 1.15M 5.68M 8.24M 7.2M 7.09K 10.39K
Free Cash Flow
-2.89M -6.29M -9.22M -12.99M -14.47M -13.78M -12.88M -8.94M -9.87M -11.69M -16.76M -22.61M -44.34M -39.76M -31.85M -25.99M -19.36K -15K